Institution identification


Institution ID


Institution full name and acronym

Centre for Pharmacoepidemiology, Karolinska Institutet (CPE-KI)

Institution countries


Type of institution

Educational Institution
Laboratory/Research/Testing facility

Institution role


Institution website

ENCePP partner

Institution description
CPE is lead by acting director Caroline Öberg. CPE's steering group includes representatives from academia, government agencies, regulatory authorities, pharmaceutical industry and Stockholm's county council. CPE strives to meet the demands from both national and international stakeholders in society and industry concerning data on drug safety, drug utilization, rational drug use and pharmacogenetics. Sweden has a unique opportunity to meet these demands by using national healthcare databases, bio banks, as well as having high levels of expertise in the fields of epidemiologically, pharmacology and other areas. CPE is mainly focusing on drug safety evaluation using data from the Swedish national registers. We have identified five research areas where we in particular can provide expert competence:
• Chronic diseases and biologics
• CNS and drugs
• Drugs during pregnancy and infancy
• Cardiovascular diseases and drugs
• Cancer and drugs.
Institution details
Experience with collecting data directly from individual patients or respondents:
Interest in carrying out research that is funded by pharmaceutical companies: